Back
Sep 30
Poster Q & A
PQA 07 - Genitourinary Cancer, Patient Safety, Nursing/Supportive Care
Presentations
-
12:45pm - 02:00pm PT
4-Year PSA Response and Long-Term Cancer Outcomes in Men Treated with Definitive External Beam Radiotherapy (EBRT) and High Dose Rate Brachytherapy Boost (HDRBT)
Speaker: Therese Kang, MBBS - Peter MacCallum Cancer Centre, Melbourne -
12:45pm - 02:00pm PT
A Dosimetric Study on SBRT Dose De-Escalation in Prostate Cancer Patients
Speaker: Taran Singh, BS - New York Institute of Technology Collage of Osteopathic Medicine, Old Westbury -
12:45pm - 02:00pm PT
A Quality Control Framework for AI-Based Contouring in Radiotherapy: Clinical Implementation and Validation
Speaker: Te Zhang, MD - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xian -
12:45pm - 02:00pm PT
A Radiation Oncologists Guide to Quality Improvement in Secondary MRI Data Sets for Treatment Planning Based on FMEA Results
Speaker: Brad Lofton, MS - Colorado Associates in Medical Physics, Colorado Springs -
12:45pm - 02:00pm PT
A Simple Two-Feature Model may Outperform Conventional Risk Classifiers for Metastasis in Prostate Cancer
Speaker: Elena Borghetti, - Huntsman Cancer Institute at the University of Utah, Salt Lake City -
12:45pm - 02:00pm PT
A Study on the Safety and Efficacy of Hyperbaric Oxygen Therapy as a First-Line Treatment for Chronic Urinary System Injury in Post-Radiotherapy Prostate Cancer Patients
Speaker: Xin Qi, MD, MS - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
A Systematic Approach to Improving Patient Compliance and Experience for Breath-Hold Radiotherapy in Breast Cancer
Speaker: Ming-Fen Lee, MS - Taiwan National Cheng Kung University Hospital, Tainan -
12:45pm - 02:00pm PT
Acute Toxicity and Patient Reported Urinary Quality of Life of Prostate Radiotherapy Following Holmium Laser Enucleation (HoLEP)
Speaker: Trevor Wilson, MD, BS - UW Health Radiation Oncology, Madison -
12:45pm - 02:00pm PT
Acute Toxicity of SBRT in Localized Prostate Cancer: A Multicenter Spanish Study
Speaker: Sigfredo Elias Romero Zoghbi, - Departament of Radiation Oncology, GenesisCare, Talavera de la Reina -
12:45pm - 02:00pm PT
Adjuvant IMRT in Locally Advanced Penile Cancer: Clinical Performance of an Institutional Inguinal Contouring Guideline
Speaker: Priyamvada Maitre, MD - Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai -
12:45pm - 02:00pm PT
An Intermittently Inflated Large-Volume Balloon Spacer for Protecting Rectum during Prostate Cancer Radiotherapy: Initial Animal Study
Speaker: Xin Qi, MD, MS - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Assessment of Non-Randomized Comparisons of Radical Prostatectomy vs. Radiation Therapy for Prostate Cancer
Speaker: Zakaria El Kouzi, MD - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Association between Intraoperative Dosimetric Parameters and Urinary Acute and Late Toxicity after Low-Dose-Rate Brachytherapy
Speaker: Arnaud Beddok, - institut Curie Paris, Paris -
12:45pm - 02:00pm PT
Associations between Obesity and Survival in Metastatic Renal Cell Cancer Patients Receiving Immunotherapy
Speaker: Hamid Ghaderi, - Medical Artificial Intelligence and Automation Laboratory, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Automated Quality Assurance for Diagnosis of Common Contouring Errors in Radiotherapy Structure
Speaker: Zijing Yang, - MedMind Technology Co., Ltd., Beijing -
12:45pm - 02:00pm PT
Breaking Barriers in Lung Cancer Screening: Understanding Provider-Level Challenges
Speaker: Akul Munjal, MD - UC Irvine Health, Orange -
12:45pm - 02:00pm PT
Cardiovascular Disease and Diagnosis of Advanced Prostate Cancer
Speaker: Kevin Nead, MD, MPhil - The University of Texas MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Changes in Prostate Volume during Prostate SBRT Delivered on an MR-Linac and Correlation with Acute Toxicity
Speaker: Jason Gurewitz, DO - NYU Langone Health, New York -
12:45pm - 02:00pm PT
Changing Landscapes of Adjuvant Radiotherapy after Prostatectomy in Prostate Cancer
Speaker: Harshath Gupta, MD - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Characteristics and Prognostic Implications of PSA Bounce in Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT)
Speaker: Andrea Romei, MD - Radiation Oncology, Careggi University Hospital, University of Florence, Florence -
12:45pm - 02:00pm PT
Clinical Correlation of Physician and Auto-Generated Contours on Post-Implant CT Following Low Dose Rate Brachytherapy
Speaker: Anirudh Bommireddy, MD - Cleveland Clinic Foundation, Cleveland -
12:45pm - 02:00pm PT
Clinical Efficacy of Salvage Re-Irradiation for Recurrent Localized Prostate Cancer Using CBCT- and Surface Mapping-Guided Proton Scanning Beams: A Single Institute Study with 32.5-Month Follow-Ups
Speaker: Charles Shang, MB, MS - South Florida Proton Therapy Institute, Delray Beach -
12:45pm - 02:00pm PT
Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center
Speaker: Filippo Alongi, MD, PhD - IRCCS Sacro Cuore Don Calabria Negrar, -
12:45pm - 02:00pm PT
Clinical Outcomes for Extracranial Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Body Radiotherapy - Institutional Experience
Speaker: Justyn Nakashima, DO - Moffitt Cancer Center, Tampa -
12:45pm - 02:00pm PT
Clinical Outcomes of Patients with Histologic Subtypes of Bladder Cancer Treated with Trimodality Therapy
Speaker: Anirudh Bommireddy, MD - Cleveland Clinic Foundation, Cleveland -
12:45pm - 02:00pm PT
Clinical Outcomes of Salvage Nodal Radiotherapy for Prostate Cancer with Prior Radiotherapy
Speaker: Maheen Ansari, BS - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Collaborative Development of a Universal Applicator Clamping Device for Brachytherapy through 3D Printing
Speaker: Ana Carolina Ahumada Pamanes, MD - Instituto Nacional de Cancerologia, Mexico City -
12:45pm - 02:00pm PT
Combination of Axitinib, Toripalimab, and Radical-Dose Radiotherapy for Recurrent or Metastatic Renal Cell Carcinoma: A Single-Center Prospective Study
Speaker: Mingwei Ma, MD - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
Combining Risk Matrix and Network Theory to Improve Risk Analysis in Radiotherapy
Speaker: Manuel Arevalo, - Universidad Nacional de Colombia, Bogota -
12:45pm - 02:00pm PT
Comparative Analysis of Lymph Node-Only vs. Bone-Only Metastasis-Directed Radiation Therapy in Oligorecurrent Prostate Cancer
Speaker: Vivek Aslot, BS - The University of Toledo College of Medicine, Toledo -
12:45pm - 02:00pm PT
Comparing PSMA PET/CT and MRI in Prostate Radiotherapy Planning: Which Modality Better Predicts Seminal Vesicle Involvement?
Speaker: Jasmesh Sandhu, - kings college hospital, LONDON -
12:45pm - 02:00pm PT
Comparing Urethral Delineation Methods in Prostate SBRT: Impact on Acute GU Toxicity
Speaker: Gargi Sharma, - Medanta The Medicity, Gurgaon -
12:45pm - 02:00pm PT
Comparison of Adaptive Magnetic Resonance Guided and Computed Tomography Guided Stereotactic Body Radiation Therapy for Prostate Cancer
Speaker: Yoonsun Jee, MD - Henry Ford Hospital-Henry Ford Cancer Institute, Detroit -
12:45pm - 02:00pm PT
Comparison of Circulating Tumor DNA and PSA after Prostate Cancer Treatment: A Retrospective Analysis
Speaker: Eleen Garemanian, - UC Irvine Health, Orange -
12:45pm - 02:00pm PT
Comparison of CT-Guided vs. MR-Guided Salvage Radiotherapy for Locally Recurrent Prostate Cancer after Radical Prostatectomy
Speaker: Jina Kim, MD - Yonsei Cancer Center, Seoul -
12:45pm - 02:00pm PT
Comparison of Patients with Early Salvage Radiotherapy and Low PSA Levels (Pre-SRT-PSA = 0.3 ng/ml) - A Retrospective Analysis of Patients with Persisting or Increasing PSA after Radical Prostatectomy for Prostate Cancer
Speaker: Reinhard Thamm, MD - Klinik fur Strahlentherapie und Radioonkologie, Ulm -
12:45pm - 02:00pm PT
Comparison of Survival and Adverse Events in Localized High-Risk Prostate Cancer Treated with IMRT+ADT vs. Trimodality Therapy (LDR-Brachytherapy + EBRT+ADT)
Speaker: Yutaka Kitagawa, MD - Tottori University Hospital, Yonago City -
12:45pm - 02:00pm PT
Conception to Development of a First-of-Its-Kind Ultra Compact, Affordable and Ergonomic Scalp Cooling System for Preventing Chemotherapy-Induced Alopecia
Speaker: Kathryn Tsai, BS - Carle Illinois College of Medicine, Urbana -
12:45pm - 02:00pm PT
CONSOLIDATE: Concurrent Radiotherapy with Enfortumab vedotin (EV) for Locally Advanced Bladder Cancer
Speaker: Patrick Carriere, MD, PhD - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Convolutional Neural Network (CNN)-Based Segmentation Method for Automatic Clinical Target Volume (CTV) Contouring in Strut-Based Applicator Brachytherapy in Breast Cancer
Speaker: Minh Nguyen, - Brody School of Medicine at East Carolina University, Greenville -
12:45pm - 02:00pm PT
Could PSMA PET/CT post Definitive Radiation Therapy (RT) and Androgen Deprivation Therapy (ADT) Detect Viable Residual Tumor with a Non-Rising PSA?
Speaker: Idan Tamir, MD - Sheba Medical Center, Ramat Gan -
12:45pm - 02:00pm PT
CT-Guided Adaptive SBRT with Simultaneous Integrated Boost for Prostate and Pelvic Nodes in High-Risk and Unfavorable Intermediate-Risk Prostate Cancer: Interim Analysis
Speaker: Weiren Liu, MD, MS - Washington University School of Medicine in St. Louis, St. Louis -
12:45pm - 02:00pm PT
Current Evidence for the Use of Reflectance Confocal Microscopy in Assessing Radiation Dermatitis
Speaker: Hamail Iqbal, BS - Cooper Medical School of Rowan University, Camden -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Daily CBCT-Based Dose Accumulation Unveils Spatial Dependency of Dominant Intraprostatic Lesion Coverage and Urinary Toxicity in Hypofractionated Prostate Radiotherapy
Speaker: Yan Gao, MD, MS - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
Determinants of First-Attempt Success in Prostate Cancer Radiation Therapy: A Prospective Study
Speaker: Karishma George, MD, MBBS, DNB - Arthur JE Child Comprehensive Cancer Centre, Calgary -
12:45pm - 02:00pm PT
Development of a Radioimmunotherapy Score for Identifying SBRT-Treated Renal Cell Carcinoma Patients Eligible for Immunotherapy
Speaker: Qingyu Huang, MD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong, China, Jinan -
12:45pm - 02:00pm PT
Is Early GU Radiation Toxicity in Prostate Cancer Patients Bladder-Related?
Speaker: Wojciech Majewski, MD, PhD - Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice -
12:45pm - 02:00pm PT
Large Language Models Applied to Patient Messages for Predicting Acute Care Risk during Radiation Therapy
Speaker: Benjamin Hyams, - UCSF School of Medicine, San Francisco -
12:45pm - 02:00pm PT
Late Genitourinary Toxicity in Prostate Cancer Patients with PRIOR Transurethral Resection of the Prostate: A Comparative Analysis of Radiotherapy with vs. without Simultaneous Integrated BOOST
Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana -
12:45pm - 02:00pm PT
Late Proctitis Rates Following Moderately-Hypofractionated Image-Guided Prostate Radiotherapy Using Fiducials vs. Cone Beam Computed Tomography
Speaker: Nancy Zhou, MD - Kaiser Permanente Los Angeles Medical Center, Los Angeles -
12:45pm - 02:00pm PT
Long Term Metastasis-Free Survival of a Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) Study
Speaker: Yutaka Shiraishi, MD, PhD - Keio University School of Medicine, Shinjuku-ku -
12:45pm - 02:00pm PT
Long-Term Bowel, Urinary, and Sexual Dysfunction Following Brachytherapy for Prostate Cancer with or without Rectal Spacer
Speaker: Michael Folkert, MD, PhD - University of Washington Radiation Oncology, Seattle -
12:45pm - 02:00pm PT
Long-Term Outcomes Following Proton Therapy for Prostate Cancer in Men Ages 50 and Younger
Speaker: Miscia Fortna, BS - UF Health Proton Therapy Institute, Jacksonville -
12:45pm - 02:00pm PT
Long-Term Results of Prostate Stereotactic Body Radiation Therapy (SBRT) with Real-Time Tracking and Novel Urethral- and Rectal-Sparing Techniques
Speaker: Katherine Amarell, MD, BS - Cleveland Clinic Foundation, Cleveland -
12:45pm - 02:00pm PT
Luminal Subtypes in Metastatic Prostate Cancer Circulating Tumor Cells Mirror Tissue and Are Associated with Prognosis and Response to 177Lu-PSMA-617
Speaker: Scot Callahan, MD, PhD - UW Carbone Cancer Center, Madison -
12:45pm - 02:00pm PT
Management of a Head and Neck Cancer Patient with a Deep Brain Stimulator Undergoing Radiation Therapy
Speaker: Nazanin Hoshyar, PhD - Bay Pines VA Medical Center, Bay Pines -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Mapping Patterns of Pelvic Lymph Node Metastasis in Bladder Urothelial Carcinoma Stratified by T-Stage and G-Grade: Implications for Personalized Pelvic Radiotherapy
Speaker: Tian Cheng, MD - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
MRI PI-RADS Lesion Location in Transitional vs. Peripheral Zone and Impact on Acute GU Toxicity Following Prostate SBRT Microboost
Speaker: Jonathan Lischalk, MD - Georgetown University School of Medicine, Washington -
12:45pm - 02:00pm PT
MRI-Defined Prostatic Gross Extracapsular Extension Association with Acute GU and GI Toxicity Following SBRT
Speaker: Jonathan Lischalk, MD - Georgetown University School of Medicine, Washington -
12:45pm - 02:00pm PT
Multi-Institutional Analysis of Extracranial Oligometastatic Bladder Cancer Patients Treated with Stereotactic Body Radiotherapy
Speaker: Ozan Cem Guler, MD - Baskent University, Adana -
12:45pm - 02:00pm PT
Multivariate Survival Analysis Comparing Proton Therapy and IMRT for Localized Prostate Cancer: A Retrospective Observational Study
Speaker: Phillip Given, BA - Eastern Virginia Medical School, Norfolk -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Online Adaptive Radiotherapy Based Integrated CT-Linac for Limited-Stage Small Cell Lung Cancer: A Prospective Phase II Trial
Speaker: Baiqiang DONG, - Sun Yat-Sen University Cancer Center, Guang Dong Province -
12:45pm - 02:00pm PT
Operational Time Savings with Prospective Peer View
Speaker: Sarah Quirk, PhD - Dana-Farber/Brigham and Womens Cancer Center, Boston -
12:45pm - 02:00pm PT
Optimizing Inter-Facility Patient Transfers for Radiation Therapy in an Integrated Health System
Speaker: Pranshu Mohindra, MD, MMM - University Hospitals Seidman Cancer Center, Cleveland, OH, Cleveland -
12:45pm - 02:00pm PT
Outcomes of Oligorecurrent Prostate Cancer Treated with Metastasis Directed Therapy
Speaker: Elizabeth Obi, MD - Cleveland Clinic Foundation, Cleveland -
12:45pm - 02:00pm PT
Outcomes of Stage IIA and Stage IIB Seminoma Treated with Definitive Radiation Therapy
Speaker: Ansel Nalin, MD, PhD - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Outcomes of Stereotactic Body Radiotherapy (SBRT) for Supraclavicular Lymph Node Metastasis (SCLN) Among Patients with Metastatic Prostate Cancer
Speaker: Andres Frias, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester -
12:45pm - 02:00pm PT
Outcomes with Salvage Dose-Escalated Intensity Modulated Proton Therapy in Node-Positive Recurrence after Prostatectomy
Speaker: Amna Gul, MD - Miami Cancer Institute, Miami -
12:45pm - 02:00pm PT
Patient Demographic Factors Associated with Radiation Cystitis Development following Radiation for Prostate Cancer
Speaker: Rachel Moses, MD - Dartmouth Health, Lebanon -
12:45pm - 02:00pm PT
Patient Education through Virtual Reality: Project Implementation
Speaker: Michelle Rokni, MS - Novant Health, Winston-Salem -
12:45pm - 02:00pm PT
Patterns and Risk Factors of Locoregional Recurrence after Radical Nephrectomy for Localized Renal Cell Carcinoma: Implications for Patient Selection in Adjuvant Radiotherapy
Speaker: Ke Hu, MD - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Physician Utilization of Low Dose Rate and High Dose Rate Brachytherapy for Prostate Cancer in Medicare Patients over a 10-Year Span (2013-2022)
Speaker: Kathryn Achuck, - Thomas Jefferson University, Philadelphia -
12:45pm - 02:00pm PT
Placing the Pin Back into the Stone Cushion: A Salvage HDR Brachytherapy Experience
Speaker: Robert Freeman, MD - Fox Chase Cancer Center, Philadelphia -
12:45pm - 02:00pm PT
Postoperative Hypofractionated Radiotherapy for Prostate Cancer: Late Toxicity and Clinical Outcomes
Speaker: Xueying Ren, MD - Radiation of Oncology, Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
PREDICT: A Machine Learning Approach to Enhanced Lymph Node Invasion Risk Assessment in Localized Prostate Cancer
Speaker: Agustin Rosich, MD - UDELAR Radioterapia, Montevideo -
12:45pm - 02:00pm PT
Predicting Response to <sup>177</sup>Lu-PSMA-617 Using Pre-Treatment Clinical Biomarkers
Speaker: Jackson Howell, MD - University of Utah Huntsman Cancer Institute, Salt Lake City -
12:45pm - 02:00pm PT
Predicting the Early Complete Biochemical Response in MRgSBRT in Prostate Cancer with Intraprostatic Lesion Boost
Speaker: Oi Lei Wong, - Hong Kong Sanatorium and Hospital, Happy Valley -
12:45pm - 02:00pm PT
Predictive Value of Pre- and Post-Treatment Tumor Apparent Diffusion Coefficient in High-Risk Prostate Cancer Patients Undergoing Definitive Radiotherapy: Long-Term Analysis from a Single-Institution Study
Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana -
12:45pm - 02:00pm PT
PREDICTO-Ren - Personalized Radiomics-basEd Determination of Individual Cancer Treatment Outcome in Patients with Renal Cancer
Speaker: Felipe Restini, MD - Hospital Sirio Libanes, Sao Paulo -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Preliminary Acute Toxicity Results of Locally Advanced Prostate Cancer Treated with MR-guided Radiotherapy
Speaker: Ezgi Oymak, MD - Sakarya Unv Egitim Arastirma Hastanesi Radyasyon Onkolojisi, Sakarya -
12:45pm - 02:00pm PT
Preliminary Outcomes of a Phase II Trial of Focal Salvage LDR Brachytherapy for Local Recurrence of Prostate Cancer following External Beam Radiation Therapy
Speaker: Ting Martin Ma, MD, PhD - University of Washington, Seattle -
12:45pm - 02:00pm PT
Preliminary Results of a Prospective Cohort Study on the Protective Effect of Bone Marrow Protection Against Lymphocytopenia during Radiotherapy in Prostate Cancer
Speaker: Huan Zhang, MD - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Prognostic Factors for Recurrence and Survival in Bladder-Preserving Therapy for Muscle-Invasive Bladder Cancer
Speaker: Nicolas Feltes, RT - mr, Sant Quirze del Vallès -
12:45pm - 02:00pm PT
Propensity Score Matched Analysis of External Beam Radiotherapy with or without Focal Boost to Intraprostatic Lesions in Prostate Cancer
Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Prostate Auto-Segmentation Model for MRI with or without Hydrogel Spacer
Speaker: Yuze Song, MS - UC San Diego Radiation Medicine and Applied Sciences, La Jolla -
12:45pm - 02:00pm PT
Prostate Reirradiation with Online Daily-Adaptive Stereotactic Body Radiotherapy (SBRT) on 1.5T MR-Linac
Speaker: Andrea Romei, MD - Radiation Oncology, Careggi University Hospital, University of Florence, Florence -
12:45pm - 02:00pm PT
Prostate Volume Reduction in Prostate Cancer: Predictive Factors after LHRHa Therapy
Speaker: Nicolas Feltes, RT - mr, Sant Quirze del Vallès -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Prostate-Specific Membrane Antigen Targeted Imaging Utilization and its Association with Disease Progression and Treatment Changes in Patients with Metastatic Hormone-Sensitive Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer
Speaker: A. Oliver Sartor, MD - Mayo Clinic Rochester, Rochester -
12:45pm - 02:00pm PT
PSA and PSMA Kinetics for Intermediate Risk, High- Very High Risk and Oligometastatic Prostate Cancer Patients Treated by Moderate Hypofractionated Radiotherapy (MHRT) and SBRT with Androgen Deprivation Therapy (ADT): A Single Center Prospective Database
Speaker: Trinanjan Basu, MD - HCG Cancer Center, Mumbai -
12:45pm - 02:00pm PT
PSA Reduction as Predictor of Biochemical Relapse in Low and Favorable Intermediate Prostate Cancer Treated with Radical Radiotherapy
Speaker: Andrea Allegra, MD - Department of Advanced Radiation Oncology, IRCSS "Sacro Cuore Don Calabria" Cancer Care Center, Negrar di Valpolicella (VR) -
12:45pm - 02:00pm PT
PSA Response to Neoadjuvant Androgen Deprivation Therapy (NA-ADT) and Long-Term Cancer Outcomes in Men Treated with Definitive External Beam Radiotherapy (EBRT) and High Dose Rate Brachytherapy Boost (HDRBT)
Speaker: Marcus Cheng, MD - Alfred Health Radiation Oncology, Melbourne -
12:45pm - 02:00pm PT
PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy
Speaker: Papaiah Susheela Sridhar, MD - Healthcare Global Enterprises Ltd., Bangalore -
12:45pm - 02:00pm PT
Quality Assurance in Head and Neck Radiation Therapy: A Prospective Analysis of Peer Review Recommendations in Disease-Site Specific Chart Rounds
Speaker: Fara Dayani, MD, MS - Kaiser Permanente Los Angeles Medical Center, Los Angeles -
12:45pm - 02:00pm PT
Quantitative magnetic resonance imaging to differentiate clinically significant tumor from other tissues in the prostate
Speaker: Kun Qing, PhD - City of Hope Antelope Valley, Lancaster -
12:45pm - 02:00pm PT
Randomized PROSTATE-IQ Trial to Reduce ADT Treatment Burden for Patients with Biochemical Recurrence after Prostatectomy
Speaker: Karen Hoffman, MD, FASTRO - The University of Texas MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
"Real World Experiences" -- from the Frontlines of a Community Practice Treating with Radiopharmaceuticals
Speaker: Vivek Mehta, MD - Swedish Cancer Institute, Seattle -
12:45pm - 02:00pm PT
Real World Utilization of Salvage Radiotherapy (SRT) in Biochemically Recurrent (BCR) Prostate Cancer Patients
Speaker: Mitchell Finkelstein, - Barrett, the Honors College Arizona State University, Tempe -
12:45pm - 02:00pm PT
Rectal-Avoidance PTV Margins in Prostate Radiation: A Large Volume Single-Institution Retrospective Series
Speaker: Ramtin Rahmani, BS - Oregon Health and Science University, Portland -
12:45pm - 02:00pm PT
Re-Defining Risk Stratification in High-Risk Prostate Cancer: Integrating Biopsy Tumor Volume for Improved Prognostic Accuracy Beyond NCCN Criteria
Speaker: Abed Rahman Kawakibi, MD - Department of Radiation and Cellular Oncology, University of Chicago, Chicago -
12:45pm - 02:00pm PT
Reduced Margin Daily AI-Assisted Online Adaptive Radiotherapy for Bladder Cancer
Speaker: Philip Blumenfeld, MD, MPH - Hadassah Medical Center, Jerusalem -
12:45pm - 02:00pm PT
Reducing Radiotherapy Anxiety: Video-Guided Education on the Radiotherapy Process
Speaker: Ting-Chun Lin, MD - China Medical University Hospital, Taichung -
12:45pm - 02:00pm PT
Risk Factor Analysis of Acute and Late Toxicity after Stereotactic Body Radiotherapy Using Prostate Cancer Patient Data from a Hydrogel Spacer Phase 2 Study
Speaker: Mami Ogita, MD, PhD - The University of Tokyo Hospital, Bunkyo-ku -
12:45pm - 02:00pm PT
Safety and Early Outcomes of External Beam Radiation Therapy with Low Dose Brachytherapy Boost in Patients with Prostate Cancer
Speaker: Zakaria El Kouzi, MD - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Safety and Efficacy of Postoperative Adjuvant Radiotherapy Combined with Immunotherapy in Patients with Upper Tract Urothelial Carcinoma
Speaker: Xiaoying Li, MD - Peking University First Hospital, Beijng -
12:45pm - 02:00pm PT
Salvage Comprehensive Nodal VMAT with PSMA PET-Guided Boost plus ADT for Node-Only Relapse After Definitive Prostate IMRT
Speaker: Haripriya Vettivelu, MD, MBBS - Mid North Coast Cancer Institute, Coffs Harbour -
12:45pm - 02:00pm PT
Salvage Re-Irradiation for Prostate Cancer: A Contemporary Prospective Experience
Speaker: Samuel Lichtman-Mikol, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland -
12:45pm - 02:00pm PT
Salvage Stereotactic Radiotherapy Post-Nephrectomy for Recurrent Renal Cell Carcinoma
Speaker: Tidie Song, BS - UT Southwestern Medical Center, Dallas -
12:45pm - 02:00pm PT
Separation Effect of Biodegradable Balloon Spacer on Rectal Dose from Apex to Base in Prostate Cancer SBRT
Speaker: Edward Soffen, MD - Princeton Radiation Oncology, Monroe -
12:45pm - 02:00pm PT
Single-cell and Bulk Transcriptomes Reveal a Two-gene Based Clinically Subtypes for Gleason Grade 5 Prostate Cancer Patients Receiving Radiotherapy
Speaker: Fuhao Wang, - Department of Radiation Oncology, Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
Social Determinants of Health in Radiation Oncology Patient Safety Incidents
Speaker: Javier Mora, MD - Harvard Radiation Oncology Program, Boston -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Spatial and Dosimetric Analysis of Local Recurrence Patterns After Trimodality Therapy for Bladder Cancer
Speaker: Matthew Whitmill, MD - UNC Health, Chapel Hill -
12:45pm - 02:00pm PT
STARLiT: A Single Arm Phase I/II Trial of STereotActic Body Radiotherapy and <sup>177</sup>Lutetium PSMA in Locally Advanced Prostate Cancer
Speaker: Qing Li, MD, PhD - UH Cleveland Medical Center, Cleveland -
12:45pm - 02:00pm PT
Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles Is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients
Speaker: Nisha Bhargava, BS - Beth Israel Deaconess Medical Center, Boston -
12:45pm - 02:00pm PT
Study of Daily Criteria-based Online Adaptive Radiotherapy with Radiomics and Dosimetry for Postoperative Prostate Cancer
Speaker: Guanghui Gan, - The First Affiliated Hospital of Soochow University, Soochow -
12:45pm - 02:00pm PT
Synthetic CT Generation for Ultrasound-Based Prostate HDR Brachytherapy Using a Cycle Diffusion Model
Speaker: Ruirui Liu, PhD - University of Nebraska Medical Center, Omaha -
12:45pm - 02:00pm PT
Telemedicine Experiences among Radiation Oncologists: A Pilot Study at an Integrated Health Care System in California
Speaker: Haocheng Cai, DO, PhD - Kaiser Permanente Los Angeles Medical Center, Los Angeles -
12:45pm - 02:00pm PT
Testosterone Recovery after Cessation of Luteinizing Hormone-Releasing Hormone Antagonists in Treatment of Prostate Cancer
Speaker: Nathan Lin, BS - City of Hope, Glendale -
12:45pm - 02:00pm PT
The Impact of ARBs and ACE Inhibitors during Chemoradiotherapy on Outcomes for Muscle Invasive Bladder Cancer
Speaker: Steven Seyedin, MD - University of California Irvine, Orange -
12:45pm - 02:00pm PT
The Impact of Femoral Head Radiation Doses on Hip Pain in Intensity Modulated Proton Therapy for Prostate Cancer: A Retrospective Analysis
Speaker: Jared Sachs, MS - South Florida Proton Therapy Institute, Delray Beach -
12:45pm - 02:00pm PT
The Impact of Neck Tilt on Deep Learning Autosegmentation Accuracy for Head and Neck Radiotherapy
Speaker: Jamison Brooks, PhD - Mayo Clinic Rochester, Rochester -
12:45pm - 02:00pm PT
The Impact of Stepwise Nutritional Intervention Combined with Individualized Nutritional Management on the Nutritional Status of Patients with Head and Neck Tumors Undergoing Radiotherapy: A Randomized Controlled Trial
Speaker: Juanli Shi, - Xijing Hospital Air Force Medical University, Xi’an -
12:45pm - 02:00pm PT
The Performance of PET and Multiparametric MRI in Identification of Intraprostatic Tumor Deposits after Prostate Radiation Therapy
Speaker: Ting Martin Ma, MD, PhD - University of Washington, Seattle -
12:45pm - 02:00pm PT
The Potential Impact of Immunotherapy on Hypofractionated Trimodality Therapy in Bladder Cancer
Speaker: Sravya Koduri, MD, BS - NYU Langone Health, New York -
12:45pm - 02:00pm PT
Timing of Molecular PET Imaging after Salvage Radiation Therapy for Recurrent Oligometastatic Castration-Sensitive Prostate Cancer
Speaker: Jarey Wang, MD, PhD - Johns Hopkins University School of Medicine, Baltimore -
12:45pm - 02:00pm PT
To Space or Not to Space: The EPIC question for Prostate Stereotactic Radiation (SBRT) with or without Hydrogel Rectal Spacer (RS)
Speaker: Madeline Flanagan, MD - Baylor College of Medicine, Houston -
12:45pm - 02:00pm PT
Toxicity Assessment of Combined External Beam Radiation with [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy
Speaker: Ross Weber, MD, PhD - Memorial Sloan Kettering Cancer Center, New York -
12:45pm - 02:00pm PT
Toxicity Outcomes in Bladder Cancer Treated with Tri-Modality Therapy Using Hypofractionated Bladder Only Radiation with or without Immunotherapy
Speaker: Andrew Wanna, MD - New York University Cancer Center, New York -
12:45pm - 02:00pm PT
Treatment Choices and Toxicity Outcomes in Patients with a High Risk PROSTOX Score
Speaker: Joanne Weidhaas, MD, PhD - UCLA Radiation Oncology, Los Angeles -
12:45pm - 02:00pm PT
Treatment Outcomes of Radiation Therapy with Androgen Deprivation Therapy in Patients with N1 Prostate Cancer
Speaker: Kayeong Shin, MD - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Trends in Cost Differences between Active Surveillance and Radiation Therapy for Low- and Favorable Intermediate-Risk Prostate Cancer
Speaker: Jiaye Shen, - Kansas University Medical Center, Kansas City -
12:45pm - 02:00pm PT
Trial in Progress: A Phase II Single-Arm Study Testing SBRT, Adenosine Signaling Modulation, and Immune Checkpoint Inhibition for Men with Hormone Sensitive Oligometastatic Prostate Cancer (SBRT-AMICO)
Speaker: Madhav Patel, MD, BS - Columbia Presbyterian Medical Center, New York -
12:45pm - 02:00pm PT
Trial in Progress: Randomized Phase II Trial of Targeted Radiation with No Castration for Treatment of Metastatic Castration-Resistant Prostate Cancer
Speaker: Sasha Ebrahimi, MD, PhD - UCLA Radiation Oncology, Los Angeles -
12:45pm - 02:00pm PT
Tri-Modality Treatment with or without Pembrolizumab for Selected Patients with Muscle-Invasive Bladder Cancer
Speaker: Shang-Bin Qin, MD - Peking University First Hospital, Beijing -
12:45pm - 02:00pm PT
TWO- vs. Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2) by MR-Linac: Interim Analysis of Circulating Lymphocyte Change in a Phase II Randomized Trial
Speaker: Ratchapas Romrattaphan, MD - Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok -
12:45pm - 02:00pm PT
Urethra Sparing in Robotic SBRT for Localized Prostate Cancer with Simultaneous Focal Boost to MR-Defined High PI-RADS Score Intra-Prostatic Lesions: A Dosimetric Analysis
Speaker: Hong Xiang, PhD, DABR - Penn Medicine Lancaster General Health, Lancaster -
12:45pm - 02:00pm PT
Urethral Dose as a Predictor of Genitourinary Toxicity and Patient-Reported Quality of Life after Prostate Stereotactic Body Radiotherapy with Focal Intraprostatic Boost: Secondary Analysis of a Phase 2 Trial
Speaker: Mustafa Basree, DO, MS - University of Wisconsin Hospitals and Clinics, Madison -
12:45pm - 02:00pm PT
Urethra-Sparing Prostate Cancer Radiotherapy: Current Practices and Future Insights from an International Survey
Speaker: Jennifer Le Guevelou, MD - Laboratoire du traitement de limage et du signal, université de Rennes, Rennes -
12:45pm - 02:00pm PT
Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines
Speaker: Jennifer Le Guevelou, MD - Laboratoire du traitement de limage et du signal, université de Rennes, Rennes -
12:45pm - 02:00pm PT
Urinary Toxicity after External Beam Radiation Therapy for Prostate Cancer following Transurethral Resection of Prostate or Laser Enucleation
Speaker: Pranalee Patel, MD, BS - Duke University School of Medicine, Durham -
12:45pm - 02:00pm PT
Using Deep Learning to Delineate the Elective Pelvic Nodal Volumes in Patients with Prostate Cancer: A Tool Aimed to Facilitate Peer Review
Speaker: Brian Anderson, PhD, MS - UNC School of Medicine, Chapel Hill -
12:45pm - 02:00pm PT
Utilization of a 46 Gene Assay Genomic Test with Clinicopathologic Factors in Unfavorable Intermediate to Very High Risk Prostate Cancer To Predict Upstaging Via PSMA PET/CT Scan
Speaker: Robert Kwon, MD - VA Long Beach Healthcare, LONG BEACH -
12:45pm - 02:00pm PT
Disparities in Access to Radiotherapy for Prostate Cancer across Brazil: A Cross-Sectional Analysis
Speaker: Andre Gouveia, MD, MBA - McMaster University, Hamilton -
12:45pm - 02:00pm PT
Dose Reconstruction for Helical Delivery Verification Using Optical Sensor Data
Speaker: Guang-Pei Chen, PhD - Medical College of Wisconsin, Milwaukee -
12:45pm - 02:00pm PT
Dose-Escalated Intensity Modulated Proton Therapy (IMPT) for Node-Positive Prostate Cancer - First Report of Clinical Outcomes
Speaker: Marcio Fagundes, MD - Miami Cancer Institute, Miami -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Early Detection of Prostate Cancer Immune Response to Radiation and Androgen Deprivation Therapy: Unleashing the Power of HRS Mpmri Imaging, Molecular Biomarkers and Digital Pathology
Speaker: Benjamin Spieler, MD - Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami -
12:45pm - 02:00pm PT
Early Outcomes from a Prospective Phase II Trial of Pencil Beam Scanning Proton SBRT for Prostate Cancer
Speaker: Daniel Gorovets, MD - Memorial Sloan Kettering Cancer Center, New York -
12:45pm - 02:00pm PT
Economic Efficiency in Radiotherapy: An Innovative Approach to Customized Bolus
Speaker: Ana Carolina Ahumada Pamanes, MD - Instituto Nacional de Cancerologia, Mexico City -
12:45pm - 02:00pm PT
Efficacy and Toxicity of PSMA-PET Guided Radiation Therapy to Newly Diagnosed Node Positive Prostate Cancer with Mesorectal Node Involvement
Speaker: Haripriya Vettivelu, MD, MBBS - Mid North Coast Cancer Institute, Coffs Harbour -
12:45pm - 02:00pm PT
Enhancing Precision in Bladder Cancer Adaptive Radiotherapy: The Benefit of Plan of the Day Treatment for Improved Target Coverage and Reducing Toxicity
Speaker: Sadia Sadiq, MBBS - Inmol hospital(Lahore)Punjab, Lahore -
12:45pm - 02:00pm PT
Enhancing Quality and Efficacy in HDR Brachytherapy for Gynecological Cancers: A Multidisciplinary Approach by Using an Auto-Alert Information System and Innovative Solutions
Speaker: Ming-Fen Lee, MS - Taiwan National Cheng Kung University Hospital, Tainan -
12:45pm - 02:00pm PT
Enhancing TG-263 Target Naming Accuracy: A WPF Application for Resident Training
Speaker: Andrew Simpson, MD - UAB Radiation Oncology, Birmingham -
12:45pm - 02:00pm PT
Estimation of a/ß Ratio for Late Genitourinary Toxicity Following Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer
Speaker: Seiya Takano, MD, PhD - Nagoya City University Graduate School of Medical Sciences, Nagoya -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Evaluating the Criteria for Cure after Low-Dose-Rate Brachytherapy for Prostate Cancer
Speaker: Kenta Onishi, MD, PhD - Department of Urology, Nara Medical University, Kashihara -
12:45pm - 02:00pm PT
Evaluating the Use of <sup>68</sup>Ga-PSMA for Biology-guided radiotherapy (BgRT) Treatment on PET-Linac Platform
Speaker: Neil Desai, MD - University of Texas Southwestern Medical Center, Dallas -
12:45pm - 02:00pm PT
Evaluation of Intra-Fraction Motion of Prostate during SBRT Using Four-Dimensional Trans Perineal Ultrasound (TPUS) and Analysis of the Data for Calculation of PTV Margins
Speaker: Amrit Neupane, MBBS - All India Institute of Medical Sciences, New Delhi -
12:45pm - 02:00pm PT
Expanding Ultra-Hypofractionated Radiotherapy: A 12-Fraction, 51.6Gy Regimen for Locally Advanced and Node-Positive Prostate Cancer
Speaker: Alina Goltser, MD - Radiation Oncology, Sheba Medical Center, Ramat Gan -
12:45pm - 02:00pm PT
Exploring Supportive Care Needs in Cancer Patients Undergoing Radiotherapy: A Latent Profile Analysis
Speaker: Yingtao Meng, - Shandong Cancer Hospital and Institute, Shandong First University, Jinan -
12:45pm - 02:00pm PT
Factors Influencing Treatment Termination in Head and Neck Cancer: Insights from a 10-Year Analysis
Speaker: Kunika Chahal, MPH, BEng - SUNY Downstate College of Medicine, New York -
12:45pm - 02:00pm PT
Focal Boosted IMRT Treatment of Prostate Cancer to 84 Gy in 28 Fractions: Extended Follow-up
Speaker: Jacob Hands, - The George Washington University School of Medicine and Health Sciences, Washington DC -
12:45pm - 02:00pm PT
From Chaos to Control: Simplifying Physics Equipment Inventory Management
Speaker: Virginia Lockamy, PhD - University of Pennsylvania, Philadelphia -
12:45pm - 02:00pm PT
Genomic Tumor Testing in NCCN Favorable and Unfavorable Intermediate-Risk Prostate Cancer Informs Treatment Intensity: Data from an Open Access Research Registry
Speaker: Christopher Lee, MD - Cancer Care Northwest, Spokane Valley -
12:45pm - 02:00pm PT
Handheld Bladder Scanners Improve Treatment Efficiency and Safety during Radiation Therapy for Prostate Cancer
Speaker: Bruce McGibbon, MD - Yale University, Trumbull -
12:45pm - 02:00pm PT
High Dose Rate Brachytherapy Boost in Intermediate and High Risk Localized Prostate Cancer: A Retrospective Study on Toxicity and Clinical Outcomes
Speaker: Mahbuba Choudhury, - Southend Hospital, Southend-on-sea -
12:45pm - 02:00pm PT
High Dose-per-Fraction Definitive Radiotherapy after Prior Ablative Treatment of Prostate Cancer
Speaker: Patrick Courtney, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles -
12:45pm - 02:00pm PT
High Rates of Treatment Regret and Recurrence with Focal Radiation Therapy: Long-Term Follow-up of a Pilot Trial for Intermediate-Risk Prostate Cancer
Speaker: Samuel Lichtman-Mikol, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland -
12:45pm - 02:00pm PT
-
12:45pm - 02:00pm PT
Identifying Intermediate-Risk Prostate Cancer Patients Appropriate for Active Surveillance Using Recursive Partitioning Analysis and Long-Term Follow-up
Speaker: Ruben Del Castillo, MD - Sunnybrook Odette Cancer Centre, Toronto -
12:45pm - 02:00pm PT
Identifying Sources of Delay to Definitive Chemoradiation for Head and Neck Cancer Patients Evaluated in a Co-Located Multidisciplinary Clinic
Speaker: Jessica Maaskant, MS, BS - Emory University School of Medicine, Atlanta -
12:45pm - 02:00pm PT
Image Quality Analysis of DL-Based sCT for Head and Neck Cancer Patients
Speaker: Moritz Westermayer, - Centre Leon Berard, Lyon -
12:45pm - 02:00pm PT
Impact of Bladder Filling on External Beam Radiotherapy for Prostate Cancer: A Mixed-Methods Analysis in a Large, Integrated Cancer Network
Speaker: Brenna Barr, CMD - UPMC Hillman Cancer Center, Pittsburgh -
12:45pm - 02:00pm PT
Impact of CT Calibration Method on Proton Plan Dosimetry
Speaker: Li Zhao, PhD - Medical College of Wisconsin, Milwaukee -
12:45pm - 02:00pm PT
Impact of Dedicated Head & Neck Cancer (HNC) Subspecialty Peer Review on Contouring Accuracy and Plan Quality in an Integrated Health Network
Speaker: Jenna Kocsis, MD - Cleveland Clinic Taussig Cancer Center, Cleveland -
12:45pm - 02:00pm PT
Impact of Pre-Therapy PSA Kinetics on Overall Survival of Prostate Cancer Patients Treated with Lu-177 PSMA 617
Speaker: Vikas Prasad, MD, PhD - Washington University School of Medicine in St. Louis, St. Louis -
12:45pm - 02:00pm PT
Impact of PSMA PET/CT on Initial Staging and Definitive Radiation Therapy Planning in Prostate Cancer
Speaker: Amr ElSaid, MD, PhD - Alexandria Clinical Oncology Department, Alexandria University, Alexandria -
12:45pm - 02:00pm PT
Impact of Rectal Spacer Implant Quality on Rectal Dose and Toxicity in Prostate Radiotherapy: Results from a Prospective Clinical Trial
Speaker: Shawn Zimberg, MD - Advanced Radiation Centers of New York, North Hills -
12:45pm - 02:00pm PT
Implementation of an Automated Quality Analytics Dashboard to Reduce Planning Bottlenecks
Speaker: Alon Witztum, PhD - University of Pennsylvania, Philadelphia -
12:45pm - 02:00pm PT
Implementing CT-Guided Online Adaptive Radiation Therapy (CT-ART) without Destroying the Clinic: A First Year Workflow
Speaker: Zachary Kiss, DO - Fox Chase Cancer Center, Philadelphia -
12:45pm - 02:00pm PT
Improving the Workflow and Rate of Scheduled Follow-up Visits within a Radiation Oncology Department
Speaker: Casey Hollawell, MD - Hospital of the University of Pennsylvania, Philadelphia -
12:45pm - 02:00pm PT
In the Eye of the Beholder: Utilizing Lean Process Improvement of Uveal Melanoma Brachytherapy Service Line to Expand Rural Oncology Equity
Speaker: Enes Atici, MD - University of Kentucky, Lexington -
12:45pm - 02:00pm PT
Innovative No-Reference Image Quality Assessment for MRI-Guided Radiotherapy: Automated Distortion Detection
Speaker: Jiayun Chen, - Cancer Hospital, Chinese Academy of Medical Sciences, Beijing -
12:45pm - 02:00pm PT
Investigating Effects of Film Digitization Methods on IROC SRS Head Phantom Credentialing Results
Speaker: Michael Yang, BS - MD Anderson Cancer Center, Houston -
12:45pm - 02:00pm PT
Investigation of the Safety of Radium-223 Chloride in Combination with External Beam Radiotherapy for Bone Metastases of Prostate Cancer
Speaker: Soichi Makino, MD - Department of Radiology (Radiation therapy), Shinkuki General Hospital, Kuki -
12:45pm - 02:00pm PT
In-Vivo Time-Resolved Optical Dosimetry with Line Measurement and Source Tracking for Prostate High-Dose-Rate Brachytherapy
Speaker: Kevin Willy, BS - Dartmouth College, Hanover